Bellevue Biotech CA CHF

WKN A2PXJ4 | ISIN CH0269987423 |  Fonds
Factsheet

Fonds

ISIN Name Performance Volatilität Sharpe Ratio
1 LU2053354390 JPMorgan Funds - Thematics - Genetic Therapies C2 (dist) - GBP (hedged) +32,44 % +20,91 % 1,42
2 LU2053354127 JPMorgan Funds - Thematics - Genetic Therapies A (dist) - GBP (hedged) +31,68 % +20,91 % 1,38
3 LU2053352774 JPMorgan Funds - Thematics - Genetic Therapies C2 (dist) - USD +31,79 % +21,17 % 1,37
4 LU2309826514 JPMorgan Funds - Thematics - Genetic Therapies C (dist) - USD +31,65 % +21,16 % 1,36
5 LU2053352691 JPMorgan Funds - Thematics - Genetic Therapies A (dist) - USD +31,04 % +21,17 % 1,34
23 CH0269987423 Bellevue Biotech CA CHF +15,21 % +20,49 % 0,61
24 IE00B3XLHR60 Polar Capital Funds plc - Biotechnology Fund Class R USD Distribution Shares +18,27 % +26,05 % 0,60
25 CH0113817065 Bellevue Biotech AA CHF +14,87 % +20,48 % 0,59
26 IE00BFX4HX56 Polar Capital Funds plc - Biotechnology Fund Class I Hedged GBP Distribution Shares +18,14 % +26,04 % 0,59
27 IE00B42P0H75 Polar Capital Funds plc - Biotechnology Fund Class I GBP Distribution Shares +16,46 % +25,70 % 0,53
28 IE00B3XDCF51 Polar Capital Funds plc - Biotechnology Fund Class R GBP Distribution Shares +15,91 % +25,71 % 0,51